NXTC Financials

NextCure Inc - Financial statements & key metrics

Stock Price

$6.80

Market Cap

$11.52M

P/E Ratio

-5.1

EPS

$-23.81

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-55.65M

EPS (Diluted)

$-1.99

Balance Sheet Highlights

Total Assets

$80.86M

Total Liabilities

$15.39M

Shareholders Equity

Cash & Equivalents

$27.73M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-40.80M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-116.9%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is NXTC revenue?

View NXTC's income statement for detailed revenue data.

Is NXTC profitable?

NXTC reported a loss of $55.65M in the most recent quarter.

What is NXTC market cap?

NXTC has a market capitalization of $11.52M, making it a small-cap stock.

Does NXTC have debt?

View NXTC's balance sheet for debt information.

What is NXTC cash flow?

Cash flow data is available in the full financial statements.